Navigation Links
Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributor's Association
Date:6/26/2008

JERUSALEM and NEEDHAM, Massachusetts, June 26 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. - (SWX: ORIDN) Oridion Medical, the leading developer and manufacturer of innovative capnography monitoring solutions, announced that it won the 2008 Manufacturers Partnership Award from IMDA, the association of medical specialty sales and marketing companies. With this award, IMDA acknowledges the Company's achievements in market development and support of its Specialty distributors (part of the Oridion Distribution Network) to increase their sales of Oridion capnography products.

The IMDA Manufacturers Partnership Award is given to the manufacturer that offers exceptional clinical and sales support, communicates frequently and openly with its Specialty distributors and responds promptly to questions, suggestions or problems. IMDA also recognized Oridion's excellent marketing as well as its active contribution to each dealer's increased revenues on the product line.

The IMDA distributor members vote on this award based on their experience with their manufacturers throughout the year. Tom Birmingham, IMDA Conference Chairman, highlighted Oridion's approach to the market by its involvement and support of major conferences and organizations like the APSF. "Oridion has high-quality support people in place and it maintains great presence at national shows," said Tom Birmingham. He added, "It also publishes excellent literature, CEU packages and educational material for the customer."

Dominic Verrilli III, Vice President of Clinical Technology, Inc. (a leading specialty distributor of medical products in the mid-western region of the United States) enthusiastically endorsed Oridion at the IMDA meeting. "Oridion provides exceptional clinical and sales supports. Their innovative Oridion Knowledge Center provides on-line clinical and sales training that is all-encompassing, simple to access and easy to use. The uniqueness of the "Capnography on Tour" marketing program has given us a foothold into new hospital areas and introduced us to new clinical champions for capnography that will help us increase our sales. Many of the companies we represent have solutions to future healthcare issues. In particular, Oridion's Microstream(R) EtCO2 technology provides the solution to a pressing patient-safety need, that is, the ability to safely monitor sedated patients!"

"Oridion is proud to have been recognized by IMDA," said Gerry Feldman, President of Oridion Capnography. "Our company's strengths are not only great products and customer support, but also the determination and creativity of our sales and clinical teams to provide our distributors with the best tools and programs to ensure growth in their sales. It aligns well with the Company's commitment to taking stress, risk and cost out of health care by improving patient safety with capnography."

Founded in 1978, IMDA is an association of sales, marketing and distribution organizations focused on bringing innovative medical technologies to market. For more information, visit http://www.imda.org

Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream(R) capnography technology has become the standard of care in ventilation monitoring.
Next financial reporting:

August 18, 2008 Results Q2 / Half Year 2008

November 10, 2008 Results Q3 / Nine Months 2008

About Oridion Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

Certain statements made herein that are not historical are forward-looking. The words "estimate" "project" "intend" "expect" "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, factors effecting OEM partners' position in the market, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology.

For further information please contact:

Alan Adler, Chairman and Chief Executive Officer

Walter Tabachnik, Chief Financial Officer

Elena Gerberg, Investor Relations

e-mail investor@oridion.com

website http://www.oridion.com

phone +972-2-589-9159

address Oridion Systems Ltd.,

P.O. Box 45025,

91450 Jerusalem,

Israel


'/>"/>
SOURCE Oridion Systems Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
2. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
3. Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers
4. Panelists Announced for 2007 Manufacturers Forum
5. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
6. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
7. Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers
8. Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the Peoples Republic of China to Wholesale Other Fertilizer Manufacturers Products
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
11. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
Breaking Biology News(10 mins):